Decentralized Clinical Trials (DCTs) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Decentralized Clinical Trials (DCTs) Market size is projected to reach US$ 14197 million by 2028, from US$ 5308 million in 2019, at a CAGR of 14% during the forecast period 2022-2028.

Distributed clinical trials (DCTs) use a method of conducting clinical trials in which part or all of a clinical trial takes place outside a traditional physical clinic or trial site. Clinical trial studies are conducted through telemedicine, mobile/local health providers, and digital/mobile technologies.

Market Segments

By Types

• Interventional
• Observational
• Expanded Access

By Applications

• Oncology
• Cardiovascular
• Others

Key Players

• Medidata
• IQVIA
• Labcorp
• PRA Health Sciences
• Parexel
• ICON
• Oracle
• CRF Health
• Clinical Ink
• Medable
• Science 37

Scope of the Report

The research study analyzes the global Decentralized Clinical Trials (DCTs) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Decentralized Clinical Trials (DCTs) Market Report

1. What was the Decentralized Clinical Trials (DCTs) Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Decentralized Clinical Trials (DCTs) Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Decentralized Clinical Trials (DCTs) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.